Gemma Barroso García
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Gemma Barroso García has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Verónica Moral Darde
Proteomic Unit, Hospital Nacional de Paraplejicos
3 shared publications - Angel Arevalo-Martin
Laboratorio de Neuroinflamacion, Hospital Nacional de Paraplejicos, SESCAM, Toledo, Spain
2 shared publications - Daniel Garcia-Ovejero
Laboratory of Neuroinflammation Hospital Nacional de Paraplejicos (SESCAM) Toledo Spain
2 shared publications - Eduardo Molina-Holgado
Laboratory of Neuroinflammation Hospital Nacional de Paraplejicos (SESCAM) Toledo Spain
2 shared publications - Maria Gonzalez Barderas
Hospital Nacional de Parapléjicos, SESCAM
2 shared publications - Tatiana Martin-Rojas
Department of Vascular Physiopathology, Hospital Nacional de Paraplejicos (HNP), SESCAM, 45071 Toledo, Spain
2 shared publications
Latest Publications
- Open Access
- 25 February 2026
- Published by Wiley in Medicine Bulletin
- Vol. 2 (2) , 155-166
Differentiating Nonsuicidal Self‐Injury (NSSI) From Suicide Attempts in Adolescents: A Pilot Study
Background: Differentiating between nonsuicidal self‐injury (NSSI) and suicide attempts (SA) in adolescents is crucial due to distinct underlying motivations, treatment needs, and potential outcomes associated with each behavior. This study explores biomarkers, specifically β ‐endorphin and endocannabinoids [anandamide (AEA), 2‐arachidonoylglycerol (2‐AG), N‐palmitoylethanolamide (PEA), and oleoylethanolamide (OEA)], in adolescents admitted for NSSI and/or SA. Objectives: We aimed to explore potential differences in different variables among adolescents hospitalized for NSSI, SA, or both. Method: This pilot study enrolled 68 adolescents admitted for NSSI and/or SA at Puerta de Hierro University Hospital. Excluding those with endocrine issues, participants underwent clinical assessments, blood collection, and serum analysis for ACTH, cortisol, and β ‐endorphin, with endocannabinoids measured via LC–MS. Clinical tools, such as the MINI Kid and CTQ and statistical analyses via SPSS and Stata aimed to elucidate behavioral and biological differences between NSSI and SA groups. Results: No sociodemographic factor differentiated the groups. Gestational diabetes and depression during pregnancy were more frequent in the NSSI group ( p = 0.047 and p = 0.003, respectively). Abnormal presentation at birth was overrepresented in the SA group ( p = 0.001). Familial antecedents of either suicide or SB were more frequently reported in the NSSI + SA group ( p = 0.027 and p = 0.035, respectively). Blood PEA and β ‐endorphin were significantly elevated in the SA group ( p < 0.006 and 0.014, respectively). Discussion: This study identified shared risk factors across NSSI and SA, with distinct variables for each group, including β ‐endorphin and PEA biomarker elevations linked to SA.
- 25 February 2026
- Published by Wiley in Medicine Bulletin
- Vol. 2 (2) , 155-166
Open AccessDifferentiating Nonsuicidal Self‐Injury (NSSI) From Suicide Attempts in Adolescents: A Pilot Study
Background: Differentiating between nonsuicidal self‐injury (NSSI) and suicide attempts (SA) in adolescents is crucial due to distinct underlying motivations, treatment needs, and potential outcomes associated with each behavior. This study explores biomarkers, specifically β ‐endorphin and endocannabinoids [anandamide (AEA), 2‐arachidonoylglycerol (2‐AG), N‐palmitoylethanolamide (PEA), and oleoylethanolamide (OEA)], in adolescents admitted for NSSI and/or SA. Objectives: We aimed to explore potential differences in different variables among adolescents hospitalized for NSSI, SA, or both. Method: This pilot study enrolled 68 adolescents admitted for NSSI and/or SA at Puerta de Hierro University Hospital. Excluding those with endocrine issues, participants underwent clinical assessments, blood collection, and serum analysis for ACTH, cortisol, and β ‐endorphin, with endocannabinoids measured via LC–MS. Clinical tools, such as the MINI Kid and CTQ and statistical analyses via SPSS and Stata aimed to elucidate behavioral and biological differences between NSSI and SA groups. Results: No sociodemographic factor differentiated the groups. Gestational diabetes and depression during pregnancy were more frequent in the NSSI group ( p = 0.047 and p = 0.003, respectively). Abnormal presentation at birth was overrepresented in the SA group ( p = 0.001). Familial antecedents of either suicide or SB were more frequently reported in the NSSI + SA group ( p = 0.027 and p = 0.035, respectively). Blood PEA and β ‐endorphin were significantly elevated in the SA group ( p < 0.006 and 0.014, respectively). Discussion: This study identified shared risk factors across NSSI and SA, with distinct variables for each group, including β ‐endorphin and PEA biomarker elevations linked to SA.
- Open Access
- 9 October 2025
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 13 (1) , 1-18
White adipose tissue undergoes pathological dysfunction in the TDP-43A315T mouse model of amyotrophic lateral sclerosis (ALS)
White adipose tissue (WAT) has a crucial role in maintaining systemic energy homeostasis. Numerous biological pathway studies have highlighted the importance of adipokines in regulating metabolic pathways and contributing to metabolic dysfunction in animal models and patients with ALS. Despite these associations, the specific molecular mechanisms remain poorly understood. Moreover, the direct contribution of WAT to the energy metabolism abnormalities observed in ALS has yet to be clearly defined. The current study sought to identify perturbances in WAT, main source of leptin, during the clinical course of the disease in TDP-43A315T mice using histological, proteomic, and molecular biological techniques. We present the first evidence of a significant histological alteration in WAT prior to the symptomatic stage of the disease in TDP-43A315T mice, providing novel insights into pathological features earlier in the onset of symptoms, and showing WAT as a target organ for ALS. In human ALS cases, we found that circulating leptin levels at the time of diagnosis were lower in the plasma of men with ALS who were overweight or obese and had rapidly progressive ALS, emphasizing the importance of considering sex-specific approaches when analysing adipokines essential for body weight control.
- 9 October 2025
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 13 (1) , 1-18
Open AccessWhite adipose tissue undergoes pathological dysfunction in the TDP-43A315T mouse model of amyotrophic lateral sclerosis (ALS)
White adipose tissue (WAT) has a crucial role in maintaining systemic energy homeostasis. Numerous biological pathway studies have highlighted the importance of adipokines in regulating metabolic pathways and contributing to metabolic dysfunction in animal models and patients with ALS. Despite these associations, the specific molecular mechanisms remain poorly understood. Moreover, the direct contribution of WAT to the energy metabolism abnormalities observed in ALS has yet to be clearly defined. The current study sought to identify perturbances in WAT, main source of leptin, during the clinical course of the disease in TDP-43A315T mice using histological, proteomic, and molecular biological techniques. We present the first evidence of a significant histological alteration in WAT prior to the symptomatic stage of the disease in TDP-43A315T mice, providing novel insights into pathological features earlier in the onset of symptoms, and showing WAT as a target organ for ALS. In human ALS cases, we found that circulating leptin levels at the time of diagnosis were lower in the plasma of men with ALS who were overweight or obese and had rapidly progressive ALS, emphasizing the importance of considering sex-specific approaches when analysing adipokines essential for body weight control.
- Open Access
Post-COVID Complications after Pressure Ulcer Surgery in Patients with Spinal Cord Injury Associate with Creatine Kinase Upregulation in Adipose Tissue
The risk of complications following surgical procedures is significantly increased in patients with SARS-CoV-2 infection. However, the mechanisms underlying these correlations are not fully known. Spinal cord injury (SCI) patients who underwent reconstructive surgery for pressure ulcers (PUs) before and during the COVID-19 pandemic were included in this study. The patient’s postoperative progression was registered, and the subcutaneous white adipose tissue (s-WAT) surrounding the ulcers was analyzed by proteomic and immunohistochemical assays to identify the molecular/cellular signatures of impaired recovery. Patients with SCI and a COVID-19-positive diagnosis showed worse recovery and severe postoperative complications, requiring reintervention. Several proteins were upregulated in the adipose tissue of these patients. Among them, CKMT2 and CKM stood out, and CKM increased for up to 60 days after the COVID-19 diagnosis. Moreover, CKMT2 and CKM were largely found in MGCs within the s-WAT of COVID patients. Some of these proteins presented post-translational modifications and were targeted by autoantibodies in the serum of COVID patients. Overall, our results indicate that CKMT2, CKM, and the presence of MGCs in the adipose tissue surrounding PUs in post-COVID patients could be predictive biomarkers of postsurgical complications. These results suggest that the inflammatory response in adipose tissue may underlie the defective repair seen after surgery.
Open AccessPost-COVID Complications after Pressure Ulcer Surgery in Patients with Spinal Cord Injury Associate with Creatine Kinase Upregulation in Adipose Tissue
The risk of complications following surgical procedures is significantly increased in patients with SARS-CoV-2 infection. However, the mechanisms underlying these correlations are not fully known. Spinal cord injury (SCI) patients who underwent reconstructive surgery for pressure ulcers (PUs) before and during the COVID-19 pandemic were included in this study. The patient’s postoperative progression was registered, and the subcutaneous white adipose tissue (s-WAT) surrounding the ulcers was analyzed by proteomic and immunohistochemical assays to identify the molecular/cellular signatures of impaired recovery. Patients with SCI and a COVID-19-positive diagnosis showed worse recovery and severe postoperative complications, requiring reintervention. Several proteins were upregulated in the adipose tissue of these patients. Among them, CKMT2 and CKM stood out, and CKM increased for up to 60 days after the COVID-19 diagnosis. Moreover, CKMT2 and CKM were largely found in MGCs within the s-WAT of COVID patients. Some of these proteins presented post-translational modifications and were targeted by autoantibodies in the serum of COVID patients. Overall, our results indicate that CKMT2, CKM, and the presence of MGCs in the adipose tissue surrounding PUs in post-COVID patients could be predictive biomarkers of postsurgical complications. These results suggest that the inflammatory response in adipose tissue may underlie the defective repair seen after surgery.
- Open Access
- 11 October 2018
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 9, 2365
Elevated Autoantibodies in Subacute Human Spinal Cord Injury Are Naturally Occurring Antibodies
Spinal cord injury (SCI) results in long-term neurological and systemic consequences, including antibody-mediated autoimmunity, which has been related to impaired functional recovery. Here we show that autoantibodies that increase at the subacute phase of human SCI, 1 month after lesion, are already present in healthy subjects and directed against non-native proteins rarely present in the normal spinal cord. The increase of these autoantibodies is a fast phenomenon–their levels are already elevated before 5 days after lesion–characteristic of secondary immune responses, further supporting their origin as natural antibodies. By proteomics studies we have identified that the increased autoantibodies are directed against 16 different nervous system and systemic self-antigens related to changes known to occur after SCI, including alterations in neural cell cytoskeleton, metabolism and bone remodeling. Overall, in the context of previous studies, our results offer an explanation to why autoimmunity develops after SCI and identify novel targets involved in SCI pathology that warrant further investigation.
- 11 October 2018
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 9, 2365
Open AccessElevated Autoantibodies in Subacute Human Spinal Cord Injury Are Naturally Occurring Antibodies
Spinal cord injury (SCI) results in long-term neurological and systemic consequences, including antibody-mediated autoimmunity, which has been related to impaired functional recovery. Here we show that autoantibodies that increase at the subacute phase of human SCI, 1 month after lesion, are already present in healthy subjects and directed against non-native proteins rarely present in the normal spinal cord. The increase of these autoantibodies is a fast phenomenon–their levels are already elevated before 5 days after lesion–characteristic of secondary immune responses, further supporting their origin as natural antibodies. By proteomics studies we have identified that the increased autoantibodies are directed against 16 different nervous system and systemic self-antigens related to changes known to occur after SCI, including alterations in neural cell cytoskeleton, metabolism and bone remodeling. Overall, in the context of previous studies, our results offer an explanation to why autoimmunity develops after SCI and identify novel targets involved in SCI pathology that warrant further investigation.
- 1 January 2017
- Published by Elsevier in Neuroscience
- Vol. 340, 333-344
Identification of axon growth promoters in the secretome of the deer antler velvet
- 1 January 2017
- Published by Elsevier in Neuroscience
- Vol. 340, 333-344
Identification of axon growth promoters in the secretome of the deer antler velvet
- Open Access
- 1 January 2015
- Published by Wiley in BioMed Research International
- Vol. 2015, 1-10
Mass Spectrometry in Pharmacokinetic Studies of a Synthetic Compound for Spinal Cord Injury Treatment
The studies of drugs that could constitute a palliative to spinal cord injury (SCI) are a continuous and increasing demand in biomedicine field from developed societies. Recently we described the chemical synthesis and antiglioma activity of synthetic glycosides. A synthetic sulfated glycolipid (here IG20) has shown chemical stability, solubility in polar solvents, and high inhibitory capacity over glioma growth. We have used mass spectrometry (MS) to monitor IG20in cells and tissues of the central nervous system (CNS) that are involved in SCI recovery. IG20 was detected by MS in serum and homogenates from CNS tissue of rats, though in the latter a previous deproteinization step was required. The pharmacokinetic parameters of serum clearance at 24 h and half-life at 4 h were determined for synthetic glycoside in the adult rat using MS. A local administration of the drug near of spinal lesion site is proposed.- 1 January 2015
- Published by Wiley in BioMed Research International
- Vol. 2015, 1-10
Open AccessMass Spectrometry in Pharmacokinetic Studies of a Synthetic Compound for Spinal Cord Injury Treatment
The studies of drugs that could constitute a palliative to spinal cord injury (SCI) are a continuous and increasing demand in biomedicine field from developed societies. Recently we described the chemical synthesis and antiglioma activity of synthetic glycosides. A synthetic sulfated glycolipid (here IG20) has shown chemical stability, solubility in polar solvents, and high inhibitory capacity over glioma growth. We have used mass spectrometry (MS) to monitor IG20in cells and tissues of the central nervous system (CNS) that are involved in SCI recovery. IG20 was detected by MS in serum and homogenates from CNS tissue of rats, though in the latter a previous deproteinization step was required. The pharmacokinetic parameters of serum clearance at 24 h and half-life at 4 h were determined for synthetic glycoside in the adult rat using MS. A local administration of the drug near of spinal lesion site is proposed. - Open Access
- 1 January 2010
- Published by SAGE Publications in Clinical Medicine Insights: Cardiology
- Vol. 4, CMC.S3884-7
Valvular Aortic Stenosis: A Proteomic Insight
Calcified aortic valve disease is a slowly progressive disorder that ranges from mild valve thickening with no obstruction of blood flow, known as aortic sclerosis, to severe calcification with impaired leaflet motion or aortic stenosis. In the present work we describe a rapid, reproducible and effective method to carry out proteomic analysis of stenotic human valves by conventional 2-DE and 2D-DIGE, minimizing the interference due to high calcium concentrations. Furthermore, the protocol permits the aortic stenosis proteome to be analysed, advancing our knowledge in this area. Until recently, aortic stenosis (AS) was considered a passive process secondary to calcium deposition in the aortic valves. However, it has recently been highlighted that the risk factors associated with the development of calcified AS in the elderly are similar to those of coronary artery disease. Furthermore, degenerative AS shares histological characteristics with atherosclerotic plaques, leading to the suggestion that calcified aortic valve disease is a chronic inflammatory process similar to atherosclerosis. Nevertheless, certain data does not fit with this theory making it necessary to further study this pathology. The aim of this study is to develop an effective protein extraction protocol for aortic stenosis valves such that proteomic analyses can be performed on these structures. In the present work we have defined a rapid, reproducible and effective method to extract proteins and that is compatible with 2-DE, 2D-DIGE and MS techniques. Defining the protein profile of this tissue is an important and challenging task that will help to understand the mechanisms of physiological/pathological processes in aortic stenosis valves.
- 1 January 2010
- Published by SAGE Publications in Clinical Medicine Insights: Cardiology
- Vol. 4, CMC.S3884-7
Open AccessValvular Aortic Stenosis: A Proteomic Insight
Calcified aortic valve disease is a slowly progressive disorder that ranges from mild valve thickening with no obstruction of blood flow, known as aortic sclerosis, to severe calcification with impaired leaflet motion or aortic stenosis. In the present work we describe a rapid, reproducible and effective method to carry out proteomic analysis of stenotic human valves by conventional 2-DE and 2D-DIGE, minimizing the interference due to high calcium concentrations. Furthermore, the protocol permits the aortic stenosis proteome to be analysed, advancing our knowledge in this area. Until recently, aortic stenosis (AS) was considered a passive process secondary to calcium deposition in the aortic valves. However, it has recently been highlighted that the risk factors associated with the development of calcified AS in the elderly are similar to those of coronary artery disease. Furthermore, degenerative AS shares histological characteristics with atherosclerotic plaques, leading to the suggestion that calcified aortic valve disease is a chronic inflammatory process similar to atherosclerosis. Nevertheless, certain data does not fit with this theory making it necessary to further study this pathology. The aim of this study is to develop an effective protein extraction protocol for aortic stenosis valves such that proteomic analyses can be performed on these structures. In the present work we have defined a rapid, reproducible and effective method to extract proteins and that is compatible with 2-DE, 2D-DIGE and MS techniques. Defining the protein profile of this tissue is an important and challenging task that will help to understand the mechanisms of physiological/pathological processes in aortic stenosis valves.
- Open Access
- 1 January 2009
- Published by SAGE Publications in Biomarker Insights
- Vol. 4, 135-64
An Optimal Protocol to Analyze the Rat Spinal Cord Proteome
Since the function of the spinal cord depends on the proteins found there, better defing the normal Spinal Cord Proteome is an important and challenging task. Although brain and cerebrospinal fluid samples from patients with different central nervous system (CNS) disorders have been studied, a thorough examination of specific spinal cord proteins and the changes induced by injury or associated to conditions such as neurodegeneration, spasticity and neuropathies has yet to be performed. In the present study, we aimed to describe total protein content in the spinal cord of healthy rats, employing different proteomics tools. Accordingly, we have developed a fast, easy, and reproducible sequential protocol for protein extraction from rat spinal cords. We employed conventional two dimensional electrophoresis (2DE) in different pH ranges (eg. 4–7, 3–11 NL) combined with identification by mass spectrometry (MALDI-TOF/TOF), as well as first dimension protein separation combined with Liquid Chromatography Mass Spectrometry/Mass Spectrometry (LC-MS/MS) to maximise the benefits of this technology. The value of these techniques is demonstrated here by the identification of several proteins known to be associated with neuroglial structures, neurotransmission, cell survival and nerve growth in the central nervous system. Furthermore this study identified many spinal proteins that have not previously been described in the literature and which may play an important role as either sensitive biomarkers of dysfunction or of recovery after Spinal Cord Injury.
- 1 January 2009
- Published by SAGE Publications in Biomarker Insights
- Vol. 4, 135-64
Open AccessAn Optimal Protocol to Analyze the Rat Spinal Cord Proteome
Since the function of the spinal cord depends on the proteins found there, better defing the normal Spinal Cord Proteome is an important and challenging task. Although brain and cerebrospinal fluid samples from patients with different central nervous system (CNS) disorders have been studied, a thorough examination of specific spinal cord proteins and the changes induced by injury or associated to conditions such as neurodegeneration, spasticity and neuropathies has yet to be performed. In the present study, we aimed to describe total protein content in the spinal cord of healthy rats, employing different proteomics tools. Accordingly, we have developed a fast, easy, and reproducible sequential protocol for protein extraction from rat spinal cords. We employed conventional two dimensional electrophoresis (2DE) in different pH ranges (eg. 4–7, 3–11 NL) combined with identification by mass spectrometry (MALDI-TOF/TOF), as well as first dimension protein separation combined with Liquid Chromatography Mass Spectrometry/Mass Spectrometry (LC-MS/MS) to maximise the benefits of this technology. The value of these techniques is demonstrated here by the identification of several proteins known to be associated with neuroglial structures, neurotransmission, cell survival and nerve growth in the central nervous system. Furthermore this study identified many spinal proteins that have not previously been described in the literature and which may play an important role as either sensitive biomarkers of dysfunction or of recovery after Spinal Cord Injury.
- 10 February 1997
- Published by Wiley in Helvetica Chimica Acta
- Vol. 80 (1) , 86-96
Lanthanide Complexes of Polyacid Ligands derived from 2, 6‐bis(pyrazol‐1‐yl)pyridine, pyrazine, and 6, 6′‐bis(pyrazol‐1‐yl)‐2, 2′‐bipyridine: Synthesis and luminescence properties
- 10 February 1997
- Published by Wiley in Helvetica Chimica Acta
- Vol. 80 (1) , 86-96
Lanthanide Complexes of Polyacid Ligands derived from 2, 6‐bis(pyrazol‐1‐yl)pyridine, pyrazine, and 6, 6′‐bis(pyrazol‐1‐yl)‐2, 2′‐bipyridine: Synthesis and luminescence properties